Several human hereditary neurological diseases are caused by expanded CAG repeats although the pathophysiological mechanism remains uncertain. Longer CAG alleles have also been reported to be over-represented in patients with bipolar disorder and schizophrenia, but the defective gene(s) remain unidentified. We isolated a human gene encoding a calcium-activated potassium channel (hSKCa3), found in neurons and containing a novel CAG repeat. Encoding a polyglutamine repeat near the amino terminus, this CAG repeat is highly polymorphic in normals, and long alleles are over-represented in schizophrenia and bipolar disorder. We now propose to combine the strengths of the four principal investigators in molecular biology, human genetics, neuroanatomy, biochemistry, and electrophysiology, to develop a detailed biophysical and pharmacological """"""""fingerprint"""""""" of this channel. Using a chimeric strategy between hKCa3 and its """"""""repeat-free"""""""" relative, hKCa4, coupled with site-specific mutagenesis, we will define functional domains within these proteins, and determine the effects of longer polyglutamine repeats on channel function. In-situ hybridization studies on human brains, from controls and patients with schizophrenia, will ascertain the neuronal distribution of hKCa3 in relation to neurotransmitter receptors and other channels, and potentially pinpoint key anatomical areas that might be implicated in schizophrenia. By defining the intron/exon organization of this gene, we will be able to initiate screening studies to identify point mutations in hKCa3 that might be associated with schizophrenia. We will also define the precise location of this gene with respect to other genetic markers for schizophrenia. The identification of the native promoter for hKCa3 will set the stage for the generation of transgenic mice that over-express hKCa3 with long polyglutamine repeats in the relevant regions of the brain; such mice might exhibit altered behavior. These experiments provide the framework for understanding the role of polyglutamine repeats in a protein of known function. The long term goal of these studies is to understand the role of hKCa3 in the pathogenesis of schizophrenia, and to develop specific modulators of this channel for potential use in the therapy of this debilitating neuropsychiatric disorder.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH059222-03
Application #
6330312
Study Section
Special Emphasis Panel (ZRG1-MDCN-3 (01))
Program Officer
Asanuma, Chiiko
Project Start
1998-12-15
Project End
2002-11-30
Budget Start
2000-12-01
Budget End
2001-11-30
Support Year
3
Fiscal Year
2001
Total Cost
$393,383
Indirect Cost
Name
University of California Irvine
Department
Physiology
Type
Schools of Medicine
DUNS #
161202122
City
Irvine
State
CA
Country
United States
Zip Code
92697
Vennekamp, Julia; Wulff, Heike; Beeton, Christine et al. (2004) Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators. Mol Pharmacol 65:1364-74
Villalobos, Claudio; Shakkottai, Vikram G; Chandy, K George et al. (2004) SKCa channels mediate the medium but not the slow calcium-activated afterhyperpolarization in cortical neurons. J Neurosci 24:3537-42
Segall, Laura; Scanzano, Rosemarie; Kaunisto, Mari A et al. (2004) Kinetic alterations due to a missense mutation in the Na,K-ATPase alpha2 subunit cause familial hemiplegic migraine type 2. J Biol Chem 279:43692-6
Kaunisto, M A; Harno, H; Vanmolkot, K R J et al. (2004) A novel missense ATP1A2 mutation in a Finnish family with familial hemiplegic migraine type 2. Neurogenetics 5:141-6
Wittekindt, Oliver H; Visan, Violeta; Tomita, Hiroaki et al. (2004) An apamin- and scyllatoxin-insensitive isoform of the human SK3 channel. Mol Pharmacol 65:788-801
Kolski-Andreaco, Aaron; Tomita, Hiroaki; Shakkottai, Vikram G et al. (2004) SK3-1C, a dominant-negative suppressor of SKCa and IKCa channels. J Biol Chem 279:6893-904
Wulff, Heike; Knaus, Hans-Gunther; Pennington, Michael et al. (2004) K+ channel expression during B cell differentiation: implications for immunomodulation and autoimmunity. J Immunol 173:776-86
Beeton, Christine; Wulff, Heike; Singh, Satendra et al. (2003) A novel fluorescent toxin to detect and investigate Kv1.3 channel up-regulation in chronically activated T lymphocytes. J Biol Chem 278:9928-37
Sun, Guifeng; Gargus, J Jay; Ta, Dennis T et al. (2003) Identification of a novel candidate gene in the iron-sulfur pathway implicated in ataxia-susceptibility: human gene encoding HscB, a J-type co-chaperone. J Hum Genet 48:415-9
Wulff, Heike; Calabresi, Peter A; Allie, Rameeza et al. (2003) The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS. J Clin Invest 111:1703-13

Showing the most recent 10 out of 26 publications